⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRLD News
Prelude Therapeutics Incorporated
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
ATTENTION PRLD Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
accessnewswire.com
PRLD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD
accessnewswire.com
PRLD
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
PRLD